NYSE: TMO
Thermo Fisher Scientific Inc Earnings & Revenue

TMO past earnings growth

How has TMO's earnings growth performed historically?
Company
5.32%
Industry
18.24%
Market
82.89%
TMO's earnings have grown faster (13.51% per year) than the US Diagnostics & Research industry average (12.63%)
Performance
TMO's earnings have grown slower (13.51% per year) than the US market average (77.34%)
Performance
TMO's earnings growth is slowing down - its growth over the last year (5.32%) is below its 5-year compound annual rate (13.51%)
Performance

TMO past revenue growth

How has TMO's revenue growth performed historically?
Company
5.55%
Industry
25.10%
Market
16.55%
TMO's revenue has grown slower (9.26% per year) than the US Diagnostics & Research industry average (16.33%)
Performance
TMO's revenue has grown slower (9.26% per year) than the US market average (15.67%)
Performance
TMO's revenue growth is slowing down - its growth over the last year (5.55%) is below its 5-year compound annual rate (9.26%)
Performance

TMO earnings and revenue history

Current Revenue
$26.2B
Current Earnings
$3.7B
Current Profit Margin
14.10%
TMO's has demonstrated consistent long-term earnings growth over the past 10 years (294.49%)
Performance

TMO Return on equity

Current Company
12.60%
Current Industry
19.70%
Current Market
-36.30%
TMO's Return on Equity (12.60%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

TMO Return on assets

Current Company
6.30%
Current Industry
5.80%
Current Market
6.20%
TMO is generating higher Return on Assets (6.30%) than the US Diagnostics & Research industry average (5.36%)
Performance

TMO Return on capital employed

Current Company
8.78%
Current Industry
9.50%
TMO has gotten more efficient at generating Return on Capital (8.78%) compared to 3 years ago (5.32%)
Performance

Thermo Fisher Scientific Earnings & Revenue FAQ

On Apr 22, 2020, Thermo Fisher Scientific (NYSE: TMO) reported Q1 2020 earnings per share (EPS) of $1.99, up 2.45% year over year. Total Thermo Fisher Scientific earnings for the quarter were $788.00 million. In the same quarter last year, Thermo Fisher Scientific's earnings per share (EPS) was $2.04.
On Apr 22, 2020, Thermo Fisher Scientific (NYSE: TMO) reported Q1 2020 revenue of $6.23 billion up 1.71% year over year. In the same quarter last year, Thermo Fisher Scientific's revenue was $6.13 billion.
As of Q4 2020, Thermo Fisher Scientific's earnings has grown 5.32% year over year. This is 12.93 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 18.24%. Thermo Fisher Scientific's earnings in the past year totalled $3.71 billion.
As of Q4 2020, Thermo Fisher Scientific's revenue has grown 5.55% year over year. This is 19.55 percentage points lower than the US Diagnostics & Research industry revenue growth rate of 25.10%. Thermo Fisher Scientific's revenue in the past year totalled $26.25 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Heap | Mobile and Web Analytics